Daniel Scherman
38Patents
11h-index
62Co-inventors
78Inventor score
Filing activity: Jul 10, 1996 → Mar 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6107286A | Lipopolyamines as transfection agents and pharamaceutical uses thereof | Human Necessities | 56 | Expired |
| US6013240A | Nucleic acid containing composition, preparation and uses of same | Human Necessities | 50 | Expired |
| US6939862B2 | Method for transferring nucleic acid into striated muscles | Human Necessities | 49 | Expired |
| US6300321A | Compounds, preparation and use for transferring nucleic acids into cells | Chemistry; Metallurgy | 42 | Expired |
| US6143530A | Circular DNA expression cassettes for in vivo gene transfer | Chemistry; Metallurgy | 37 | Expired |
| US5945400A | Nucleic acid-containing composition, preparation and use thereof | Chemistry; Metallurgy | 36 | Expired |
| US6171612A | Lipopolyamines as transfection agents and pharmaceutical uses thereof | Physics | 23 | Expired |
| US6200956A | Nucleic acid-containing composition, preparation and use thereof | Chemistry; Metallurgy | 21 | Expired |
| US6172048A | Composition containing nucleic acids, preparation and uses | Human Necessities | 13 | Expired |
| US6528315B2 | Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor | Human Necessities | 11 | Expired |
| US6492164B1 | Circular DNA expression cassettes for gene transfer | Chemistry; Metallurgy | 11 | Expired |
| US6287762A | Purification of a triple helix formation with an immobilized oligonucleotide | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5846947A | Composition containing nucleic acids, preparation and uses | Human Necessities | 8 | Expired |
| US8039445B2 | Methods and devices for delivering a therapeutic product to the ocular sphere of a subject | Human Necessities | 7 | Active |
| US6319672A | Purification of a triple helix formation with an immobilized oligonucleotide | Emerging Cross-Sectional Technologies | 7 | Expired |
| US9487782B2 | Methods for the treatment of leber congenital amaurosis | Emerging Cross-Sectional Technologies | 7 | Active |
| US5821038A | Yeast with modified permeability | Chemistry; Metallurgy | 4 | Expired |
| US7038026B2 | Purification of a triple heli formation with an immobilized oligonucleotide | Chemistry; Metallurgy | 4 | Expired |
| US6825341B2 | Process for preparing functionalized polyalkyleneimines, compositions containing them and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US9012425B2 | Methods for the treatment of Leber congenital amaurosis | Emerging Cross-Sectional Technologies | 3 | Active |
| US9474782B2 | Use of decorin for increasing muscle mass | Human Necessities | 3 | Active |
| US8709383B2 | Persistent luminescence nanoparticles used in the form of a diagnosis agent for in vivo optical imaging | Performing Operations; Transporting | 3 | Active |
| US6521252B1 | Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applications | Chemistry; Metallurgy | 2 | Expired |
| US9777272B2 | Methods for the treatment of Leber congenital amaurosis | Emerging Cross-Sectional Technologies | 2 | Active |
| US7622566B2 | Purification of a triple helix formation with an immobilized oligonucleotide | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.